Dr. Anette Müllertz is a distinguished professor and internationally recognized expert in pharmaceutical sciences with specialization in oral drug delivery systems. She currently serves as Professor in the Department of Pharmacy at the University of Copenhagen, where she also directs the Bioneer-FARMA Center, Denmark's premier drug development hub. Holding both an M.Sc. in Engineering and a PhD in Chemical Engineering from the Technical University of Denmark, she has established a distinguished career spanning over three decades in pharmaceutical research. Her professional journey began at Novo Nordisk A/S as a Research Scientist before progressing through academic appointments at the Royal Danish School of Pharmacy and ultimately assuming leadership roles at the University of Copenhagen since 2000.
Professor Müllertz's pioneering research has fundamentally transformed the understanding of oral drug delivery mechanisms, particularly for poorly soluble compounds that represent significant formulation challenges in modern pharmacology. Her groundbreaking work on lipid-based drug delivery systems has provided critical insights into dissolution and solubilization processes within the gastrointestinal tract, establishing novel methodologies for predicting drug bioavailability. She has developed sophisticated media that accurately simulate gastrointestinal fluids and created advanced digestion models that elucidate complex drug solubilization pathways. Her integrative research bridging in vitro models with human bioavailability studies has significantly enhanced the pharmaceutical industry's capacity to predict clinical performance of innovative formulations, effectively closing the translational gap between laboratory research and therapeutic outcomes.
Beyond her research excellence, Professor Müllertz has profoundly influenced pharmaceutical education by supervising over forty master's theses and teaching advanced courses in drug delivery since 2004. She maintains a prominent scholarly role as a longstanding member of the Editorial Advisory Board for the Journal of Pharmaceutical Sciences, contributing to the field's intellectual discourse since 2004. As director of Bioneer-FARMA, she spearheads a collaborative ecosystem connecting academic researchers with industry partners to accelerate Denmark's pharmaceutical innovation pipeline. Her ongoing research continues to focus on developing predictive in vitro models for drug absorption and pioneering pharmaceutical formulations that address the persistent challenge of poorly soluble drugs, ensuring her scientific contributions maintain direct relevance to both pharmaceutical development and patient-centered care.
